Dr. Smith to Speak at the International ALS MND Meeting, December 6-8, 2024

The title of his talk is "Seed-Amplification Assays: Windows into ALS and Kindred Diseases".

June 2024 - Qalsody (Tofersen) Approved For Use in Europe

Qualsody/Toferson conceived by CNS Director Dr. Smith and developed in collaboration with Don Cleveland (UCSD), Tim Miller (WashU), and Frank Bennett (Ionis Pharmaceuticals), has been approved by the European Union for the treatment of a familial form of Amyotrophic lateral sclerosis (ALS). Read more here.

April 16th, 2024 - "Chinese Translation and Validation of the Center for Neurologic Study Lability Scale" Published

The open access version of "Chinese Translation and Validation of the Center for Neurologic Study Lability Scale" has been published in the online library of Neurology and Therapy and can be accessed here: https://link.springer.com/article/10.1007/s40120-024-00605-w?utm_source=rct_congratemailt&utm_medium=email&utm_campaign=oa_20240416&utm_content=10.1007/s40120-024-00605-w